Literature DB >> 1664304

Comparison of inotropic and chronotropic responses in rat isolated atria and ventricles.

L Brown1, C Sernia, R Newling, P Fletcher.   

Abstract

1. The positive inotropic and chronotropic responses to adrenoceptor agonists (noradrenaline, phenylephrine), to compounds which increase cAMP by post-adrenoceptor mechanisms (forskolin, theophylline and dibutyryl cAMP) and to calcium chloride were measured in isolated rat atria and papillary muscles from both ventricles. 2. Noradrenaline produced similar maximal inotropic responses to calcium chloride in all tissues. Forskolin gave similar responses to calcium chloride in atrial but not ventricular tissues; the reverse was observed with dibutyryl cAMP. Phenylephrine and theophylline produced significantly smaller inotropic responses than calcium chloride in all tissues, especially in ventricular tissues. 3. Maximal chronotropic responses to noradrenaline, theophylline and dibutyryl cAMP were similar. Forskolin produced significantly greater responses while calcium chloride and phenylephrine produced significantly smaller responses than noradrenaline. 4. These results show that the maximal positive inotropic response of some agonists is markedly dependent on the tissue chosen. Further, chronotropic responses in right atria do not mimic inotropic responses in left atria.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1664304     DOI: 10.1111/j.1440-1681.1991.tb01393.x

Source DB:  PubMed          Journal:  Clin Exp Pharmacol Physiol        ISSN: 0305-1870            Impact factor:   2.557


  2 in total

1.  Reversal of cardiac and renal fibrosis by pirfenidone and spironolactone in streptozotocin-diabetic rats.

Authors:  G Miric; C Dallemagne; Z Endre; S Margolin; S M Taylor; L Brown
Journal:  Br J Pharmacol       Date:  2001-07       Impact factor: 8.739

2.  Attenuation of cardiac fibrosis by pirfenidone and amiloride in DOCA-salt hypertensive rats.

Authors:  Stevo Mirkovic; Anne-Marie L Seymour; Andrew Fenning; Anna Strachan; Solomon B Margolin; Stephen M Taylor; Lindsay Brown
Journal:  Br J Pharmacol       Date:  2002-02       Impact factor: 8.739

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.